However, these innate antiviral responses (including type I interferons (IFNα/β) or type III IFN (IFNλ) have been shown to be impaired in the early phase of COVID-19, contributing to a viral persistence with an overwhelming host-damaging proinflammatory response12. This evidence concerns the gene IFNA1 and COVID-19.